Abstract
Effect of Levonorgestrel-Releasing Intrauterine System on Sexual and Urinary Functions
Highlights
The levonorgestrel-intrauterine system (LNG-IUS; Mirena® Leiras Oy, Turku, Finland) has been used worldwide for various clinical indications, such as menorrhagia and dysmenorrhea, in addition to its common use as a contraceptive since it was first commercially introduced in 1990 [1]
Menorrhagia and chronic pelvic pain negatively affect the quality of life as well as sexual and urinary functions of women [4,5,6,7,8,9]
In a study in which mean satisfaction was evaluated in women using LNG-IUS, 95% women were satisfied with this system and 99% women selected the same method at the end of 5 years [27]
Summary
The levonorgestrel-intrauterine system (LNG-IUS; Mirena® Leiras Oy, Turku, Finland) has been used worldwide for various clinical indications, such as menorrhagia and dysmenorrhea, in addition to its common use as a contraceptive since it was first commercially introduced in 1990 [1]. Menorrhagia and chronic pelvic pain negatively affect the quality of life as well as sexual and urinary functions of women [4,5,6,7,8,9]. In cases of unresponsiveness to medical treatment, radical elimination of abnormal uterine bleeding by hysterectomy may worsen sexual and urinary functions. The LNG-IUS is an effective, reliable, reversible and relatively less invasive low cost therapy to treat menorrhagia, endometrial hyperplasia, and dysmenorrhea [11]
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
